Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

This study has been completed.
Information provided by (Responsible Party):
Marcia Brose, University of Pennsylvania Identifier:
First received: April 1, 2008
Last updated: June 20, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)